Rifaxa 200 mg Tablets contain Rifaximin B.P, a broad-spectrum, non-absorbable antibiotic used for the treatment of traveler’s diarrhea and other gastrointestinal infections caused by susceptible bacteria, acts locally in the intestine by inhibiting bacterial RNA synthesis, reduces pathogenic gut flora, and helps restore normal intestinal function with minimal systemic absorption.

Dosage:
Traveler’s diarrhea: 200 mg three times daily for 3 days,
Other intestinal infections: as prescribed by the physician based on severity and indication.

Side Effects:
Common: nausea, abdominal pain, bloating, flatulence, headache,
Less common/serious: vomiting, constipation, allergic reactions, skin rash, elevated liver enzymes,
Precautions: Use with caution in patients with severe liver disease. Discontinue if hypersensitivity occurs; consult a physician before prolonged use.

Rifaxa 200 mg Tablets (Rifaximin B.P) for traveler’s diarrhea and gastrointestinal infections, exported internationally by AQ Ventures.